Evidence map›Paper›PMID 36421254›Full record

ArticleAntibiotics (Basel, Switzerland)2022

A Novel Machine Learning-Based Point-Score Model as a Non-Invasive Decision-Making Tool for Identifying Infected Ascites in Patients with Hydropic Decompensated Liver Cirrhosis: A Retrospective Multicentre Study.

Silvia Würstle, Alexander Hapfelmeier, Siranush Karapetyan, Fabian Studen, Andriana Isaakidou, Tillman Schneider, Roland M Schmid, Stefan von Delius, Felix Gundling, Julian Triebelhorn and 12 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 2 countries.

Silvia WürstleDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0003-0787-3894
Alexander HapfelmeierInstitute of General Practice and Health Services Research, School of Medicine, Technical University of Munich, 81667 Munich, Germany.ORCID 0000-0001-6765-6352
Siranush KarapetyanInstitute of AI and Informatics in Medicine, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Fabian StudenDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Andriana IsaakidouDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-2680-8492
Tillman SchneiderDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-5431-2507
Roland M SchmidDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Stefan von DeliusDepartment of Internal Medicine II, RoMed Hospital Rosenheim, 83022 Rosenheim, Germany.
Felix GundlingDepartment of Gastroenterology, Hepatology, and Gastrointestinal Oncology, Bogenhausen Hospital of the Munich Municipal Hospital Group, 81925 Munich, Germany.
Julian TriebelhornDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Rainer BurgkartClinic of Orthopaedics and Sports Orthopaedics, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Andreas ObermeierClinic of Orthopaedics and Sports Orthopaedics, School of Medicine, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-1774-5194
Ulrich MayrDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Stephan HellerClinic of Orthopaedics and Sports Orthopaedics, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Sebastian RaschDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Tobias LahmerDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Fabian GeislerDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Benjamin ChanDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06520, USA.
Paul E TurnerDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06520, USA.
Kathrin RotheInstitute for Medical Microbiology, Immunology and Hygiene, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Christoph D SpinnerDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-3875-5367
Jochen SchneiderDepartment of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-0300-0159
TUM Klinikum · DETechnical University of Munich · DEYale University · USInstitute of Medical Microbiology and Hygiene · DEMünchen Klinik Bogenhausen · DERoMed Kliniken · DE

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

This study is aimed at assessing the distinctive features of patients with infected ascites and liver cirrhosis and developing a scoring system to allow for the accurate identification of patients not requiring abdominocentesis to rule out infected ascites. A total of 700 episodes of patients with decompensated liver cirrhosis undergoing abdominocentesis between 2006 and 2020 were included. Overall, 34 clinical, drug, and laboratory features were evaluated using machine learning to identify key differentiation criteria and integrate them into a point-score model. In total, 11 discriminatory features were selected using a Lasso regression model to establish a point-score model. Considering pre-test probabilities for infected ascites of 10%, 15%, and 25%, the negative and positive predictive values of the point-score model for infected ascites were 98.1%, 97.0%, 94.6% and 14.9%, 21.8%, and 34.5%, respectively. Besides the main model, a simplified model was generated, containing only features that are fast to collect, which revealed similar predictive values. Our point-score model appears to be a promising non-invasive approach to rule out infected ascites in clinical routine with high negative predictive values in patients with hydropic decompensated liver cirrhosis, but further external validation in a prospective study is needed.

Indexed as

ascitesliver cirrhosisproton pump inhibitorsecondary peritonitisspontaneous bacterial peritonitis

Identifiers

PMID36421254
PMCPMC9686825
OpenAlexW4308971916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.